PA Consulting Group gives insight into commercial exploitation of nanomedicine for advance...


Mark Humphries from PA Consulting Group - the leading international management systems and technology consultancy - will provide key insights into the exploitation of nanotechnology for advanced drug delivery in his paper 'Evaluating emerging technologies' at SMi's Drug Delivery Global Summit at 11.

30am tomorrow (21 September 2005) in London.

Mark, a Consultant in Product and Process Engineering in PA's Global Technology Group, will consider the benefits nanotechnology can bring to advanced drug delivery and issues which need to be addressed before the technology can be successfully deployed.

The paper will consider two time horizons:

  • How the specific attributes of nanotechnology can be utilised in the short to mid-term to increase performance and the commercial life cycle of existing therapies

  • How longer term advances in combined delivery routes, activation technologies, imaging technologies, and instrumentation will provide opportunities for targeted drug delivery.

    The opportunities afforded range from: revenue optimisation, patent extension and differentiation from generic competition in the nearer term, through to developing new functionality and new therapeutic regimens in the longer term. The benefits include increased efficacy and specificity with reduced toxicity. New material preparation technologies, improved process technologies and analytical characterisation and measurement methods will be needed to provide a complete solution.

    The paper will be of particular value to developers and business managers involved in new therapeutic solutions.

    In presenting the paper Mark, a member of PA's management team, will draw from 18 years' experience designing and developing new products and processes and exploiting emerging technologies.

    Drug Delivery Global Summit - Evaluating emerging technologies, 21 + 22 September 2005, Jurys Gt Russell Street Hotel, London

    PA supports clients' drug discovery, development, manufacturing and commercialisation activities from strategy to successful implementation. Our organisation is unique in that we invest heavily in our two technology centres in the US and UK. With over 200 scientists and engineers from the life sciences industry, we design, develop and deliver pharmaceutical products, drug-delivery devices, and novel scientific instruments.

    PA's health sector consulting expertise covers advising on and implementing new health policy, improving performance against targets, providing IT solutions to enable delivery of change, managing delivery of change, supporting organisational development, and modelling and analysing data to provide healthcare management information.

    PA Consulting Group is a leading management, systems and technology consulting firm. Operating worldwide in more than 35 countries, PA draws on the knowledge and experience of 3,000 people, whose skills extend from the initial generation of ideas, insights and solutions all the way through to detailed implementation.

    From the development of innovative strategies and solutions right through to their successful delivery, all of our work and support is based on deep sector insight and expertise. We work across the private and public sectors, with particular strengths in financial services, energy, life sciences & healthcare, government & public services, manufacturing and telecommunications. We help our clients to design optimum strategies for growth, deliver effective IT that improves business performance, mobilize human resources, deliver complex programmes and major business transformations, and develop breakthrough products and processes through our unique applied technology capability.

    As an employee-owned company, with no audit arm nor exclusive alliances with third-party vendors or service providers, we are answerable to our clients and ourselves only. This independence means the advice we give to clients, and the work we deliver, is unencumbered by any considerations other than what is best for our clients' business.

    PA's independent, benefits-driven approach is founded on our strength in innovation, our responsiveness to our clients' needs, and our unyielding focus on delivery:

    Innovation. Innovation comes in a variety of forms -- in how customers' needs are identified and satisfied, in business models, in motivating and aligning staff, in the use of technology, and many more. PA has an unsurpassed track record in innovation, from developing pharmaceutical anti-counterfeiting measures and wireless technologies, to helping launch an innovative online bank, to development work that is helping alleviate poverty and boost the economies of developing countries.

    Responsiveness. We recognize that each client and each problem has its own challenges and issues. Our solutions are therefore tailored to our clients' specific circumstances, drawing on the deep industry insight of our consultants. Our relationships with clients are characterized by respect, flexibility and collaboration, and we pride ourselves on the speed of our response and the dedication of our people.

    Delivery. At PA, delivering client value is ingrained in our culture. We focus on detailed implementation, with a renowned track record of delivering innovative solutions that achieve lasting change. At PA, we see projects right through to the finishing line -- and beyond -- delivering significant and measurable value to our clients.

    PA: Innovation. Responsiveness. Delivery.


    For more information please contact:

    Mark Humphries +44 (0)1763 267481 email:

    John O'Neill +44 (0)1763 267133 email: John O'

    PA Consulting Group, Cambridge Technology Centre, Melbourn, Herts. Tel +44 (0)1763 267492 email:
  • To read more information, click here.

    PA Consulting Group is an innovation and transformation consultancy. We believe in the power of ingenuity to build a positive human future in a technology-driven world.

    PA Consulting